Related Experiment Video
Updated: May 27, 2026
10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
Temporal compartmental dosing effects for robotic prostate stereotactic body radiotherapy
Stephen L Shiao1, Arjun Sahgal, Weigang Hu
1Department of Radiation Oncology, University of California, San Francisco, CA, USA.
Physics in Medicine and Biology
|November 24, 2011
Summary
CyberKnife stereotactic body radiotherapy delivers consistent biological doses for prostate cancer, similar to continuous large-field radiation. This study found non-isocentric small-field delivery tracks well with constant-dose-rate methods.
Area of Science:
- Radiation Oncology
- Medical Physics
Background:
- Non-isocentric radiotherapy systems like CyberKnife can have variable dose accumulation rates within target volumes.
- Understanding intra-target temporal dose distribution is crucial for accurate biological effective dose calculation.
Purpose of the Study:
- To investigate if temporal dose variations in CyberKnife treatments significantly alter the biological equivalent dose (EUD).
- To compare the EUD of actual CyberKnife treatments with theoretical continuous irradiation for prostate cancer.
Main Methods:
- Reconstructed time courses from ten prostate cancer patients undergoing CyberKnife treatment.
- Calculated biologically equivalent uniform dose (EUD) using the linear quadratic model (α/β = 3).
- Compared actual EUDs with theoretical EUDs from continuous large-field irradiation.
Main Results:
- Actual CyberKnife EUDs strongly correlated with theoretical large-field delivery EUDs (R² = 0.98).
- Average EUD for CyberKnife was slightly higher (5.0 ± 4.7%) than large-field delivery.
- No statistically significant difference (p = 0.21) was found between the two delivery methods.
Conclusions:
- Non-isocentric small-field CyberKnife delivery provides consistent biological dosing for prostate SBRT.
- The biological dosing achieved with CyberKnife closely mimics that of constant-dose-rate, large-field delivery.
